Altropane I-123 Uses, Dosage, Side Effects and more
Altropane I-123 is under investigation in clinical trial NCT01950468 (A Cross-Over, Multi-Center Trial to Evaluate the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes).
Trade Name | Altropane I-123 |
Generic | Altropane I-123 |
Type | |
Formula | C18H21FINO2 |
Weight | Average: 425.275 Monoisotopic: 425.061230027 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |